Let’s Talk CMV and Beyond 2026

We invite you to engaging sessions covering key updates on the International Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation, ECILs guidelines and patient cases

Physicians and nurses working in hematology, infectious diseases, cardiology, pulmonary medicine, gastroenterology, renal medicine, and transplantation.

Join us for an interactive Nordic meeting.
We invite you to an engaging session covering key updates on the ”Fourth International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation”

This is a unique opportunity to engage with leading experts, gain valuable insights, and participate in dynamic discussions.

Time: March 25th, 2026, 16.30 -17.30 (CET), 17.30 -18.30 Finnish time
Place: Webinar

AGENDA 25th of March

SPEAKER

Ilkka Helanterä, Prof. MD, PhD, Adj. Transplantation and Liver Surgery, Helsinki University Hospital
Susanne Dam Poulsen,Prof. Infection specialist, Rigshospitalet Copenhagen

REGISTER TO MEETING

For more information and registration for
webinar on 25th of March, please click here  
Please register before 21st of March 2026

VÄLKOMMEN

Emma Silfverswärd
Brand and Customer Manager
M: +46 705 216 373
emma.silfversward@takeda.com

Birgitta Trangius
Key Account Manager
Immunology
M: +46 70-552 13 55
birgitta.trangius@takeda.com

Christina Kristensson
Key Account Manager
Immunology
M: +46 73-840 82 48
christina.kristensson@takeda.com

This meeting is initiated, organized and funded by Takeda. Takeda covers, in accordance with LER, speaker fees within the framework of the meeting. Participation in the meeting is free of
charge. According to the agreement on information and education between the Swedish Association of the Pharmaceutical Industry (Läkemedelsindustriföreningen) and SKL, this invitation to the training has been sent as a copy to your operations manager as well as the relevant pharmaceutical committee. The mailing has been sent using information from the Healthcare Address Register (HSAR) by Takeda Pharma AB, which is affiliated with the HSAR Data Protection Program. Further information about address details and registration can be obtained via www.hsar.se or from IQVIA, +46 8-555 214 20.
C-ANPROM/SE/CMV/0007 02/2026